Leerink Partners Maintains Outperform on AdaptHealth, Raises Price Target to $8

Benzinga · 2d ago
Leerink Partners analyst Whit Mayo maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and raises the price target from $7 to $8.